This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
Journal of Ovarian Research Open Access 08 February 2021
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Blay, J., Négrier, S., Philip, T. et al. Pretreatment serum CRP and response to interleukin 2. Br J Cancer 69, 200–201 (1994). https://doi.org/10.1038/bjc.1994.35
Issue Date:
DOI: https://doi.org/10.1038/bjc.1994.35
This article is cited by
-
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
Journal of Ovarian Research (2021)
-
C-reactive protein as a biomarker for urological cancers
Nature Reviews Urology (2011)
-
Treatment for renal cancer: are we beyond the cytokine era?
Nature Clinical Practice Urology (2006)